ELECTROCARDIOGRAPHIC CHANGES INDUCED BY COLD APPLICATION TO VARIOUS BODY SITES IN PATIENTS WITH ANGINA PECTORIS–PRELIMINARY REPORT

B. Berman,J. Mcguire

DOI: https://doi.org/10.1097/00000441-195001000-00013

1950-01-01

Abstract:

What problem does this paper attempt to address?

Patients' and Providers' Needs and Preferences When Considering Fertility Preservation Before Cancer Treatment: Decision-Making Needs Assessment

Aubri Hoffman,Laura Crocker,Aakrati Mathur,Deborah Holman,June Weston,Sukhkamal Campbell,Ashley Housten,Andrea Bradford,Shilpi Agrawala,Terri L Woodard

DOI: https://doi.org/10.2196/25083

2021-06-07

Abstract:Background: As cancer treatments continue to improve, it is increasingly important that women of reproductive age have an opportunity to decide whether they want to undergo fertility preservation treatments to try to protect their ability to have a child after cancer. Clinical practice guidelines recommend that providers offer fertility counseling to all young women with cancer; however, as few as 12% of women recall discussing fertility preservation. The long-term goal of this program is to develop an interactive web-based patient decision aid to improve awareness, access, knowledge, and decision making for all young women with cancer. The International Patient Decision Aid Standards collaboration recommends a formal decision-making needs assessment to inform and guide the design of understandable, meaningful, and usable patient decision aid interventions. Objective: This study aims to assess providers' and survivors' fertility preservation decision-making experiences, unmet needs, and initial design preferences to inform the development of a web-based patient decision aid. Methods: Semistructured interviews and an ad hoc focus group assessed current decision-making experiences, unmet needs, and recommendations for a patient decision aid. Two researchers coded and analyzed the transcripts using NVivo (QSR International). A stakeholder advisory panel guided the study and interpretation of results. Results: A total of 51 participants participated in 46 interviews (18 providers and 28 survivors) and 1 ad hoc focus group (7 survivors). The primary themes included the importance of fertility decisions for survivorship, the existence of significant but potentially modifiable barriers to optimal decision making, and a strong support for developing a carefully designed patient decision aid website. Providers reported needing an intervention that could quickly raise awareness and facilitate timely referrals. Survivors reported needing understandable information and help with managing uncertainty, costs, and pressures. Design recommendations included providing tailored information (eg, by age and cancer type), optional interactive features, and multimedia delivery at multiple time points, preferably outside the consultation. Conclusions: Decision making about fertility preservation is an important step in providing high-quality comprehensive cancer care and a priority for many survivors' optimal quality of life. Decision support interventions are needed to address gaps in care and help women quickly navigate toward an informed, values-congruent decision. Survivors and providers support developing a patient decision aid website to make information directly available to women outside of the consultation and to provide self-tailored content according to women's clinical characteristics and their information-seeking and deliberative styles.
A Decision Aid Intervention for Family Building After Cancer: Developmental Study on the Initial Steps to Consider When Designing a Web-Based Prototype

Catherine Benedict,Katherine L Dauber-Decker,D'Arcy King,Alexandria Hahn,Jennifer S Ford,Michael Diefenbach

DOI: https://doi.org/10.2196/20841

2021-01-22

Abstract:Background: An important aspect of patient-centered care involves ensuring that patient-directed resources are usable, understandable, and responsive to patients' needs. A user-centered design refers to an empathy-based framework and an iterative design approach for developing a product or solution that is based on an in-depth understanding of users' needs, values, abilities, and limitations. Objective: This study presents the steps taken to develop a prototype for a patient resource for young women who have completed treatment for gonadotoxic cancer to support their decision making about follow-up fertility care and family building. Methods: User-centered design practices were used to develop Roadmap to Parenthood, a decision aid (DA) website for family building after cancer. A multidisciplinary steering group was assembled and input was provided. Guidelines from the International Patient DA Society and the Ottawa Decision Support Framework were used throughout the development process. In addition, guidelines for developing health DAs with respect to patient diversity and health literacy were also followed. Results: The Roadmap to Parenthood DA website prototype was systematically and iteratively developed. An extensive process of designing and developing solutions from the perspective of the end user was followed. The steps taken included formative work to identify user needs; determining goals, format, and delivery; design processes (eg, personas, storyboards, information architecture, user journey mapping, and wireframing); and content development. Additional design considerations addressed the unique needs of this patient population, including the emotional experiences related to this topic and decision-making context wherein decisions could be considered iteratively while involving a multistep process. Conclusions: The design strategies presented in this study describe important steps in the early phases of developing a user-centered resource, which will enhance the starting point for usability testing and further design modifications. Future research will pilot test the DA and a planning tool, and evaluate improvement in the decisional conflict regarding family building after cancer. Consistent with a patient-centered approach to health care, the strategies described here may be generalized and applied to the development of other patient resources and clinical contexts to optimize usability, empathy, and user engagement.
The "Begin Exploring Fertility Options, Risks and Expectations" (BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients

Brittany Speller,Kelly Metcalfe,Erin D Kennedy,Marcia Facey,Ellen Greenblatt,Adena S Scheer,Ellen Warner,Anil Abraham Joy,Frances C Wright,Nancy N Baxter

DOI: https://doi.org/10.1186/s12911-019-0912-y

2019-10-28

Abstract:Background: Premenopausal breast cancer patients are at risk of treatment-related infertility. Many patients do not receive sufficient fertility information before treatment. As such, our team developed and alpha tested the Begin Exploring Fertility Options, Risks, and Expectations decision aid (BEFORE DA). Methods: The BEFORE DA development process was guided by the International Patient Decision Aids Standards and the Ottawa Decision Support Framework. Our team used integrated knowledge translation by collaborating with multiple stakeholders throughout the development process including breast cancer survivors, multi-disciplinary health care providers (HCPs), advocates, and cancer organization representatives. Based on previously conducted literature reviews and a needs assessment by our team - we developed a paper prototype. The paper prototype was finalized at an engagement meeting with stakeholders and created into a graphically designed paper and mirrored online decision aid. Alpha testing was conducted with new and previously engaged stakeholders through a questionnaire, telephone interviews, or focus group. Iterative reviews followed each step in the development process to ensure a wide range of stakeholder input. Results: Our team developed an 18-page paper prototype containing information deemed valuable by stakeholders for fertility decision-making. The engagement meeting brought together 28 stakeholders to finalize the prototype. Alpha testing of the paper and online BEFORE DA occurred with 17 participants. Participants found the BEFORE DA usable, acceptable, and most provided enthusiastic support for its use with premenopausal breast cancer patients facing a fertility decision. Participants also identified areas for improvement including clarifying content/messages and modifying the design/photos. The final BEFORE DA is a 32-page paper and mirrored online decision aid ( https://fertilityaid.rethinkbreastcancer.com ). The BEFORE DA includes information on fertility, fertility options before/after treatment, values clarification, question list, next steps, glossary and reference list, and tailored information on the cost of fertility preservation and additional resources by geographic location. Conclusion: The BEFORE DA, designed in collaboration with stakeholders, is a new tool for premenopausal breast cancer patients and HCPs to assist with fertility discussions and decision-making. The BEFORE DA helps to fill the information gap as it is a tool that HCPs can refer patients to for supplementary information surrounding fertility.
High Speed Downlink Packet Access (HSDPA) - Enhanced Data Rates for UMTS Evolution

I. Forkel,Hartmut Klenner,A. Kemper

DOI: https://doi.org/10.1016/j.comnet.2005.05.012

2005-10-19

Abstract:
Occupational allergic contact dermatitis from vitamin A acetate

M. Heidenheim,G. Jemec

DOI: https://doi.org/10.1111/J.1600-0536.1995.TB02091.X

1995-12-01

Contact Dermatitis

Abstract:Case Report A 44-year-old man, without previous skin disease, was employed in industrial production of vitamins. The job consisted of drying, sieving and packing of vitamin A (vitamin A acetate=retinyl acetate). After 3 months, he developed eczema on the dorsum of the hands, face, neck, arms, trunk, despite use of gloves, protective suit with cuffs/wristlets, and mask. Treatment with topical corticosteroids was initially effective. Following repeated attacks, the eczema persisted despite cleansing the skin and topical treatment, whereupon the patient stopped working with vitamin A. After change of job, the eczema disappeared. The patient was not taking any medication or vitamin supplements, and at the time of referral, he had no visible dermatitis or other skin diseases. Patch tests with the European standard series were negative. The results of patch tests with vitamin A acetate and its additives are given in Table I. Blood tests revealed increased levels of carotene, 3.41 yM/1 (ref.: 0.76-3.33), and vitamin A (retinol), 3.14 yM/1 (0.9-2.16). Vitamin A acetate was also tested at 0.1 %, 0.5%, 1%, 5% and 10% pet. in a control group of 97 contact dermatitis patients. No positive ( + or more) reactions were seen, but 6 doubtful (?+) reactions were seen to 5% and 10%, and I to 1%.
MEAD (part I)--a mathematical model of the long-term dispersion of radioactivity in shelf sea environments.

J. Goshawk,S. Clarke,C. N. Smith,P. McDonald

DOI: https://doi.org/10.1016/S0265-931X(03)00040-7

IF: 2.655

Journal of Environmental Radioactivity

Abstract:
Addressing decisional conflict about fertility preservation: helping young female cancer survivors’ family planning decisions

Madleina Müller,Corinne Urech,Jacky Boivin,Verena Ehrbar,Rebecca Moffat,Rosanna Zanetti Daellenbach,Christoph Rochlitz,Sibil Tschudin

DOI: https://doi.org/10.1136/bmjsrh-2017-101820

2017-11-17

Abstract:Background Health professionals are challenged by a growing number of young long-term cancer survivors with their specific needs with regard to family planning. This study aimed at assessing decisional conflict (DC) in young female cancer patients regarding fertility preservation, identifying demographic, fertility and fertility preservation related factors, which may affect DC, and assessing the helpfulness of various decision-supports. Methods A retrospective, cross-sectional, web-based survey via an online questionnaire available in three languages with specific items concerning cancer, fertility, fertility preservation and the validated Decisional Conflict Scale targeted at current or former female cancer patients aged 18–45 years, with cancer types or treatment potentially affecting reproductive function. Results The 155 participating women showed considerable DC, especially with regard to missing information and support. DC was significantly lower in patients when the risk of infertility was discussed with a health professional, when they had undergone any procedure to preserve fertility, and when they had a university education. A longer time interval since cancer diagnosis was associated with higher DC. The most helpful decision-support tools were specialised websites and leaflets. Conclusions Young female cancer patients’ DC with regard to fertility preservation is very high. Information and support seem to be deficient. More information through standardised information tools might be an effective strategy to lower their DC at the time when treatment decisions need to be taken, and to improve their reproductive health after they have overcome cancer in the future.

social sciences, biomedical,obstetrics & gynecology,family studies
[Microplate for high throughput screening of 6-hydroxynicotinic acid transforming strains].

Yao Yang,S. Yuan,Yijun Dai,G. Shang

Abstract:Recently, new insecticides containing 3-chloropyridylmethyl group as a versatile building block have been developed, among which imidachloprid is a promising one. The synthesis of imidachloprid can use 6-Hydroxynicotinic acid, the first intermediate of the bacterial degradation of nicotinic acid, as a starting material. It is difficult to hydroxylate nicotinic acid at C6 position in a chemical synthesis. However, biotransformation can produce 6-hydroxynicotinic acid with industrial application possibility. Therefore, methods for large scale screening of 6-hydroxynicotinic acid-producing microorganisms are urgent. A high through-put screening method for 6-hydroxynicotinic acid transforming strains was established by determining 6-hydroxynicotinic acid based on 96-well Microplate-Multiskan Spectrum. The determination wavelength and the reference wavelength of 6-hydroxynicotinic acid were 251nm and 231nm respectively. Beer's law is obeyed in the range of 0.5-11 microg/mL (R2 = 0.9999) for measuring 6-hydroxynicotinic acid. The average recovery rate was 99.11%-100.81%. The results showed that there was no apparent difference between our microplate method and previous HPLC method in the detecting 6-hydroxynicotinic acid formation. The microplate method is simple, convenient and accurate. It has the potential for large scale (about 2000 - 5000 reactions/d) screening of 6-hydroxynicotinic acid-producing microorganisms.
Development of an Electronic Decision Aid Tool to Facilitate Mainstream Genetic Testing in Ovarian Cancer Patients

Kristen M Shannon,Devanshi Patel,Jessica M Jonas,Erica L Blouch,Stephanie R Hicks,Mackenzie Wooters,Meredith Seidel,Carly F Grant,Margaret M Emmet,Daniel C Chung,Karen Sepucha

DOI: https://doi.org/10.1093/oncolo/oyad328

2024-01-31

The Oncologist

Abstract:Abstract Background Multigene panel testing is an important component of cancer treatment plans and risk assessment, but there are many different panel options and choosing the most appropriate panel can be challenging for health care providers and patients. Electronic tools have been proposed to help patients make informed decisions about which gene panel to choose by considering their preferences and priorities. Materials and Methods An electronic decision aid (DA) tool was developed in line with the International Patient Decision Aids Standards collaboration. The multidisciplinary project team collaborated with an external health care communications agency and the MGH Cancer Center Patient and Family Advisory Council (PFAC) to develop the DA. Surveys of genetic counselors and patients were used to scope the content, and alpha testing was used to refine the design and content. Results Surveys of genetic counselors (n = 12) and patients (n = 228) identified common themes in discussing panel size and strategies for helping patients decide between panels and in identifying confusing terms for patients and distribution of patients’ choices. The DA, organized into 2 major sections, provides educational text, graphics, and videos to guide patients through the decision-making process. Alpha testing feedback from the PFAC (n = 4), genetic counselors (n = 3) and a group of lay people (n = 8) identified areas to improve navigation, simplify wording, and improve layout. Conclusion The DA developed in this study has the potential to facilitate informed decision-making by patients regarding cancer genetic testing. The distinctive feature of this DA is that it addresses the specific question of which multigene panel may be most suitable for the patient. Its acceptability and effectiveness will be evaluated in future studies.

oncology
Decision aids for female BRCA mutation carriers: a scoping review

McGarrigle,S. A.,Prizeman,G.,Spillane,C.,Byrne,N.,Drury,A.,Polus,M.,Mockler,D.,Connolly,E. M.,Brady,A.-M.,Hanhauser,Y. P.

DOI: https://doi.org/10.1136/bmjopen-2023-076876

IF: 3.006

2024-06-15

BMJ Open

Abstract:Objectives Women who inherit a pathogenic BRCA1 or BRCA2 mutation are at substantially higher risk of developing breast and ovarian cancer than average. Several cancer risk management strategies exist to address this increased risk. Decisions about which strategies to choose are complex, personal and multifactorial for these women. Decision aids (DAs) are tools that assist patients in making health-related decisions. The aim of this scoping review was to map evidence relating to the development and testing of patient DAs for cancer unaffected BRCA mutation carriers. Design Scoping review conducted according to the Joanna Briggs Institute's (JBI's) scoping review methodological framework. Data sources MEDLINE, EMBASE, CINAHL, Web of Science. No restrictions applied for language or publication date. A manual search was also performed. Eligibility criteria for selecting studies Studies on DAs for cancer risk management designed for or applicable to women with a pathogenic BRCA1 or BRCA2 mutation who are unaffected by breast or ovarian cancer. Data extraction and synthesis Data were extracted using a form based on the JBI instrument for extracting details of studies' characteristics and results. Data extraction was performed independently by two reviewers. Extracted data were tabulated. Results 32 evidence sources relating to development or testing of 21 DAs were included. Four DAs were developed exclusively for cancer unaffected BRCA mutation carriers. Of these, two covered all guideline recommended risk management strategies for this population though only one of these was readily available publicly in its full version. All studies investigating DA effectiveness reported a positive effect of the DA under investigation on at least one of the outcomes evaluated, however only six DAs were tested in randomised controlled trials. Conclusion This scoping review has mapped the landscape of the literature relating to developing and testing, DAs applicable to cancer unaffected BRCA mutation carriers.

medicine, general & internal
Pathways: patient-centred decision counselling for women at risk of cancer-related infertility: a protocol for a comparative effectiveness cluster randomised trial

Terri Lynn Woodard,Aubri S Hoffman,Laura C Crocker,Deborah A Holman,Derek B Hoffman,Jusheng Ma,Roland L Bassett Jr,Viola B Leal,Robert J Volk

DOI: https://doi.org/10.1136/bmjopen-2017-019994

IF: 3.006

2018-02-21

BMJ Open

Abstract:Introduction: National guidelines recommend that all reproductive-age women with cancer be informed of their fertility risks and offered referral to fertility specialists to discuss fertility preservation options. However, reports indicate that only 5% of patients have consultations, and rates of long-term infertility-related distress remain high. Previous studies report several barriers to fertility preservation; however, initial success has been reported using provider education, patient decision aids and navigation support. This protocol will test effects of a multicomponent intervention compared with usual care on women's fertility preservation knowledge and decision-making outcomes. Methods and analysis: This cluster-randomised trial will compare the multicomponent intervention (provider education, patient decision aid and navigation support) with usual care (consultation and referral, if requested). One hundred newly diagnosed English-speaking women of reproductive age who are at risk of cancer-related infertility will be recruited from four regional oncology clinics.The Pathways patient decision aid website provides (1) up-to-date evidence and descriptions of fertility preservation and other family-building options, tailored to cancer type; (2) structured guidance to support personalising the information and informed decision-making; and (3) a printable summary to help women prepare for discussions with their oncologist and/or fertility specialist. Four sites will be randomly assigned to intervention or control groups. Participants will be recruited after their oncology consultation and asked to complete online questionnaires at baseline, 1 week and 2 months to assess their demographics, fertility preservation knowledge, and decision-making process and quality. The primary outcome (decisional conflict) will be tested using Fisher's exact test. Secondary outcomes will be assessed using generalised linear mixed models, and sensitivity analyses will be conducted, as appropriate. Ethics and dissemination: The University of Texas MD Anderson Cancer Center provided approval and ongoing review of this protocol. Results will be presented at relevant scientific meetings and submitted for publication in a peer-reviewed journal. Trial registration number: NCT03141437; Pre-results.
Fertility decision-making in cancer patients – current status and future directions

Verena Ehrbar,Corinne Urech,Sibil Tschudin

DOI: https://doi.org/10.1080/23809000.2018.1503539

2018-07-04

Expert Review of Quality of Life in Cancer Care

Abstract:Introduction: With long-term cancer survivor rates increasing, quality of life, and a pivotal component of it, the ability to procreate are of growing importance. As treatment can compromise fertility, patients need to be informed about the currently available options to preserve it. However, decisional conflict may arise, as decisions have to be made within the short time frame after diagnosis and before treatment. Areas covered: Decisional conflict reflects the personal perception of uncertainty in choosing between different options. It is typical in decision-making in the context of fertility preservation (FP). It comprises factors such as feeling uninformed, lack of clarity regarding personal values, lack of support, and uncertainty and is associated with decisional regret. Research has shown that additional support tools such as decision aids have the potential to increase knowledge and reduce decisional conflict. Expert commentary: Improvement in the availability of and access to adequate and personalized support for all young cancer patients concerning FP is needed. Information provision should be comprehensive and tailored to individual needs and ideally complemented with a decision aid. Future research should focus on more individualized decision aids and on the male perspective, as existing decision aids are targeted at female cancer patients.
Preliminary testing of "roadmap to parenthood" decision aid and planning tool for family building after cancer: Results of a single‐arm pilot study

Catherine Benedict,Jennifer S. Ford,Lidia Schapira,Alexandra Davis,Pamela Simon,David Spiegel,Michael Diefenbach

DOI: https://doi.org/10.1002/pon.6323

2024-04-19

Psycho-Oncology

Abstract:Objective Many young adult female cancer survivors need to use reproductive medicine, surrogacy, or adoption to have a child. This study pilot tested Roadmap to Parenthood, a web‐based, self‐guided decision aid and planning tool for family building after cancer (disease agnostic). Methods A single‐arm pilot study tested feasibility, acceptability, and obtained effect size estimates of the Roadmap tool. Participants, recruited via hospital‐based and social media strategies, completed a baseline survey (T1), accessed the Roadmap tool (website), then completed surveys at one‐ and 3‐months (T2 and T3, respectively). Feasibility and acceptability were evaluated with rates of eligibility, enrollment, and survey completion, and feedback. Pairwise t‐tests and repeated measures ANOVA evaluated usage effects. Effect size estimates were calculated. Results Participants (N = 98) averaged 31 years old (SD = 5.61); 71% were nulliparous. Enrollment rate was 73%, T1‐T2 completion rate was 80%, and 93% accessed the website. From T1‐T2, participants reported improvements in decisional conflict (p

oncology,social sciences, biomedical,psychology, multidisciplinary
Formative development of a fertility decision aid for transgender adolescents and young adults: a multidisciplinary Delphi consensus study

Victoria D Kolbuck,Afiya Sajwani,Moira A Kyweluk,Courtney Finlayson,Elisa J Gordon,Diane Chen

DOI: https://doi.org/10.1007/s10815-020-01947-8

Abstract:Purpose: No educational and decision support tools exist to aid transgender and non-binary (TNB) adolescents and young adults (AYA) in making decisions about fertility preservation in the context of initiating gender-affirming medical care that can impair fertility. This study identified critical content areas and learning objectives to include in a decision aid about fertility preservation targeted for TNB AYA. Methods: Delphi methodology was leveraged to engage 80 multidisciplinary experts in reproductive medicine and pediatric transgender health care in a two round consensus building procedure. Proposed content areas rated as "probably keep" or "definitely keep" by 75% of experts were retained. Proposed learning objectives reaching 75% agreement on ratings of importance and priority were also identified. Results: The Delphi procedure identified five priority content areas (Basic Reproduction; Gender-Affirming Medical Interventions: Impacts on Fertility; Established Fertility Preservation Options; Benefits and Risks of Established Fertility Preservation Procedures; Alternative Pathways to Parenting) and 25 learning objectives to prioritize in a fertility-related decision aid for TNB AYA. Conclusion: A multidisciplinary panel of experts achieved agreement around content areas and learning objectives to incorporate into a decision aid about fertility preservation for TNB AYA.
Direct and indirect effects of chronic physical conditions on depression: a preliminary investigation.

R. Vilhjálmsson

DOI: https://doi.org/10.1016/S0277-9536(98)00119-1

1998-09-01

Social Science & Medicine (1967)

Abstract:
Development and Evaluation of an Educational E-Tool to Help Patients With Non-Hodgkin's Lymphoma Manage Their Personal Care Pathway

Jozette JC Stienen,Petronella B Ottevanger,Lianne Wennekes,Helena M Dekker,Richard WM van der Maazen,Caroline MPW Mandigers,Johan HJM van Krieken,Nicole MA Blijlevens,Rosella PMG Hermens

DOI: https://doi.org/10.2196/resprot.3407

2015-01-09

JMIR Research Protocols

Abstract:BACKGROUND: An overload of health-related information is available for patients on numerous websites, guidelines, and information leaflets. However, the increasing need for personalized health-related information is currently unmet.OBJECTIVE: This study evaluates an educational e-tool for patients with non-Hodgkin's lymphoma (NHL) designed to meet patient needs with respect to personalized and complete health-related information provision. The e-tool aims to help NHL patients manage and understand their personal care pathway, by providing them with insight into their own care pathway, the possibility to keep a diary, and structured health-related information.METHODS: Together with a multidisciplinary NHL expert panel, we developed an e-tool consisting of two sections: (1) a personal section for patients' own care pathway and their experiences, and (2) an informative section including information on NHL. We developed an ideal NHL care pathway based on the available (inter)national guidelines. The ideal care pathway, including date of first consultation, diagnosis, and therapy start, was used to set up the personal care pathway. The informative section was developed in collaboration with the patient association, Hematon. Regarding participants, 14 patients and 6 laymen were asked to evaluate the e-tool. The 24-item questionnaire used discussed issues concerning layout (6 questions), user convenience (3 questions), menu clarity (3 questions), information clarity (5 questions), and general impression (7 questions). In addition, the panel members were asked to give their feedback by email.RESULTS: A comprehensive overview of diagnostics, treatments, and aftercare can be established by patients completing the questions from the personal section. The informative section consisted of NHL information regarding NHL in general, diagnostics, therapy, aftercare, and waiting times. Regarding participants, 6 patients and 6 laymen completed the questionnaire. Overall, the feedback was positive, with at least 75% satisfaction on each feedback item. Important strengths mentioned were the use of a low health-literacy level, the opportunity to document the personal care pathway and experiences, and the clear overview of the information provided. The added value of the e-tool in general was pointed out as very useful for preparing the consultation with one's doctor and for providing all information on one website, including the opportunity for a personalized care pathway and diary. The majority of the revisions concerned wording and clarity. In addition, more explicit information on immunotherapy, experimental therapy, and psychosocial support was added.CONCLUSIONS: We have developed a personal care management e-tool for NHL patients. This tool contains a unique way to help patients manage their personal care pathway and give them insight into their NHL by providing health-related information and a personal diary. This evaluation showed that our e-tool meets patients' needs concerning personalized health-related information, which might serve as a good example for other oncologic diseases. Future research should focus on the possible impact of the e-tool on doctor-patient communication during consultations.

English Else
Interaction of bupropion and zinc with neuronal nicotinic acetylcholine receptors

J. García-Colunga,Ulises Godoy-García,E. Vázquez-Gómez

DOI: https://doi.org/10.1016/j.neuropharm.2011.07.009

IF: 5.273

2011-12-01

Neuropharmacology

Abstract:
Temperature Measurement of Molten Pig Iron With Slag Characterization and Detection Using Infrared Computer Vision

R. Usamentiaga,J. Molleda,D. García,J. C. Granda,J. Rendueles

DOI: https://doi.org/10.1109/TIM.2011.2178675

IF: 5.6

2012-05-01

IEEE Transactions on Instrumentation and Measurement

Abstract:Accurate temperature measurement in industrial environments is as important as it is challenging. Precise control over temperature measurement is crucial when processing metals, such as iron or steel, where temperature monitoring is critical to productivity and product quality. In the steel manufacturing process, temperature measurement of molten pig iron is particularly important, as it is a required parameter of the physical models used to control operations in steel furnaces. However, measuring the temperature of molten pig iron is not an easy task. Conventional methods using thermocouples or pyrometers present serious drawbacks which limit their applicability and do not provide accurate measurements. In this paper, an infrared computer vision system is proposed to measure the temperature of molten pig iron while it is being poured. The proposed system confronts two challenges: The stream must be detected in the infrared images, and the slag, which can partially cover the stream of molten pig iron, must be detected and removed from the stream. Fast, robust, and accurate methods are proposed. A calibration procedure for the emissivity of the molten pig iron and for the temperature level is also proposed and applied. This procedure makes it possible to differentiate molten pig iron from slag in the stream. Tests indicate that the results meet production needs.
Patient Decision Aids for Breast Cancer Reconstruction: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Yunjhen Su,Chin-Yu Sun,Wen-Kuan Chiu,Yi-No Kang,Chiehfeng Chen

DOI: https://doi.org/10.1097/prs.0000000000011292

2024-01-15

Plastic & Reconstructive Surgery

Abstract:Background: Breast cancer has surpassed lung cancer to become the most frequently diagnosed cancer in women. There has been a dramatic increase in the use of breast reconstruction after mastectomy. However, struggle in making decisions regarding breast reconstruction has existed. Thus, decision aid (DA) is necessary to be conducted, and further studies are needed to promote better decision aid. This review discussed how DAs can be used to help women make decisions about breast reconstruction after mastectomy. Additionally, the review was the first to compare different DA formats to determine which one is most effective. Methods: We searched for relevant studies published before October 2022 in PubMed and Embase using the medical subject headings “breast reconstruction” and “decision aid.” Demographic data as well as decision, outcomes and instruments used for assessment were also collected. Risk of bias was measured by the Cochrane Risk-of-Bias 2 (RoB 2) tool. Results: A network meta-analysis of 14 RCTs with a total of 1401 patients wereincluded. 90.9% participants presented usable results for evaluation of decisional conflict, and web-based DA (-0.3, 95% CI -0.56 to -0.05) showed significant improvement. 50.3% participants provided results of decisional regret, and no subgroups showed significant reduction. 60.3% participants contributed to results for knowledge, and web-based DA (0.61, 95% CI 0.01 to 1.21) showed the most positive effect. 44.5% participants were included for evaluation of satisfaction, and web-based DA (0.44, 95% CI 0.15 to 0.72) revealed significant increase. Conclusion: The review concluded that web-based decision aids are the favorable format of decision aid.

surgery
Web-based Guidance for Assisted Reproductive Technology With an Online App (myFertiCare): Quantitative Evaluation With the HOT-fit Framework

Ellen Marie Sparidaens,Jade G M Logger,Willianne L D M Nelen,Didi D M Braat,Kathrin Fleischer,Rosella P M Hermens

DOI: https://doi.org/10.2196/38535

IF: 7.076

2023-01-24

Journal of Medical Internet Research

Abstract:Background Assisted reproductive technologies (ARTs) are considered to be physically and mentally stressful. During their treatment trajectory, couples express high information and communication needs. They appreciate using the internet to obtain fertility-related information. In a previous study, we developed myFertiCare, an eHealth tool providing personalized information and interactive functionalities for infertile couples in order to improve patient-centered care. The app has already been successful in qualitative evaluations of usability. Objective The aim of the current study is to quantitatively evaluate the implementation of myFertiCare by using the human, organizational, and technology–fit (HOT-fit) framework and to study the effects of using myFertiCare on couples’ knowledge about infertility, their experience of the burden of infertility, and their experience of patient-centered care. With these results, implementation can be further improved, and patient-centered care can be enhanced. Methods A quantitative study was performed based on the HOT-fit framework using validated questionnaires focusing on the human, organizational, and technology domains. Questions were added on the effect of using myFertiCare on couples’ knowledge about infertility and treatment. Questions regarding the burden of infertility, the burden of infertility treatment, and the experience of patient-centeredness were based on the main items of the validated fertility quality of life (FertiQoL) and Patient-Centredness Questionnaire–Infertility questionnaires, respectively. Also, nonusers of the app were included to explore motivations for not using the app and identify opportunities for improvement. Finally, user data were analyzed to provide insight into multiple variables concerning app use. Results In the human and technology domains, myFertiCare showed good system usability, high user satisfaction, and high information and interface quality. In the organizational domain, implementation was considered to be sufficient by both patients and staff. Use of the app increased knowledge about the treatment, improved coping with the treatment, and enhanced the experience of patient-centeredness. User data showed that women were the main app users and that use of the app gradually declined during the treatment trajectory. Conclusions A multi-faceted online app, myFertiCare, has been successfully evaluated quantitatively for implementation by using the HOT-fit framework. Use of the app increased knowledge about the treatment, improved coping with the treatment, and enhanced the experience of patient-centeredness. App use could be improved by creating more publicity. By providing myFertiCare, professionals in fertility care are supported in guiding patients through their treatment trajectory and in delivering patient-centered care.

health care sciences & services,medical informatics

ELECTROCARDIOGRAPHIC CHANGES INDUCED BY COLD APPLICATION TO VARIOUS BODY SITES IN PATIENTS WITH ANGINA PECTORIS–PRELIMINARY REPORT

Patients' and Providers' Needs and Preferences When Considering Fertility Preservation Before Cancer Treatment: Decision-Making Needs Assessment

A Decision Aid Intervention for Family Building After Cancer: Developmental Study on the Initial Steps to Consider When Designing a Web-Based Prototype

The "Begin Exploring Fertility Options, Risks and Expectations" (BEFORE) decision aid: development and alpha testing of a fertility tool for premenopausal breast cancer patients

High Speed Downlink Packet Access (HSDPA) - Enhanced Data Rates for UMTS Evolution

Occupational allergic contact dermatitis from vitamin A acetate

MEAD (part I)--a mathematical model of the long-term dispersion of radioactivity in shelf sea environments.

Addressing decisional conflict about fertility preservation: helping young female cancer survivors’ family planning decisions

[Microplate for high throughput screening of 6-hydroxynicotinic acid transforming strains].

Development of an Electronic Decision Aid Tool to Facilitate Mainstream Genetic Testing in Ovarian Cancer Patients

Decision aids for female BRCA mutation carriers: a scoping review

Pathways: patient-centred decision counselling for women at risk of cancer-related infertility: a protocol for a comparative effectiveness cluster randomised trial

Fertility decision-making in cancer patients – current status and future directions

Preliminary testing of "roadmap to parenthood" decision aid and planning tool for family building after cancer: Results of a single‐arm pilot study

Formative development of a fertility decision aid for transgender adolescents and young adults: a multidisciplinary Delphi consensus study

Direct and indirect effects of chronic physical conditions on depression: a preliminary investigation.

Development and Evaluation of an Educational E-Tool to Help Patients With Non-Hodgkin's Lymphoma Manage Their Personal Care Pathway

Interaction of bupropion and zinc with neuronal nicotinic acetylcholine receptors

Temperature Measurement of Molten Pig Iron With Slag Characterization and Detection Using Infrared Computer Vision

Patient Decision Aids for Breast Cancer Reconstruction: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Web-based Guidance for Assisted Reproductive Technology With an Online App (myFertiCare): Quantitative Evaluation With the HOT-fit Framework